Cronin, Timothy K. http://orcid.org/0000-0001-7446-6258
Ronayne, Cian
O’Donovan, Niamh
McGuinness, Eimear
Cooke, Katie
Dennehy, Maeve
Dennehy, Colum
Power, Derek G.
Cahill, Mary R. http://orcid.org/0000-0002-1655-3078
Collins, Dearbhaile C.
Connolly, Roisin M. http://orcid.org/0000-0003-0056-1070
Bambury, Richard M. http://orcid.org/0000-0002-2189-6972
Mykytiv, Vitaliy
Higgins, Michaela J. http://orcid.org/0000-0002-9065-8652
Noonan, Sinéad A. http://orcid.org/0000-0002-7752-3876
O’Reilly, Seamus http://orcid.org/0000-0002-2887-7336
Funding for this research was provided by:
Breakthrough Cancer Research
University College Cork
Article History
Received: 7 June 2023
Accepted: 2 May 2024
First Online: 28 May 2024
Declarations
:
: DC has received consultant fees from Genmab, Merck Sharp, and Dohme (MSD); research funding from Pfizer; travel expenses from Roche, MSD, and Genmab; and honoraria from Amgen, Pfizer, Roche, and MSD. RC has received an unrestricted educational grant from Pfizer and research funding for clinical trials from MSD Ireland, Pfizer, Daichii Sankyo, and Astra Zeneca; all to her institution. RC has consulted for Astra Zeneca/Daichii, Gilead, and Seagen. She has received travel support from Novartis. RB has received educational grants from Pfizer, Astellas, and Jannsen. He is co-founder of Portable Medical Technology. MH has received consultant fees from MSD and travel expenses from Roche. SN is a former employee of MSD and has received honoraria from Pfizer and meeting registration expenses from Pfizer, MSD, and Roche. SOR has received consultant fees from Astrazeneca; travel expenses from Astrazeneca, Pfizer, Novartis, and Roche; and honoraria from Novartis, Roche, and Pfizer.